Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +207.46%
#3 ONFA ONFA +54.25%
#4 Metaplex Metaplex +23.96%
#5 Osaka Protocol Osaka Protocol +21.73%
#6 Talus Network Talus Network +20.44%
#7 Wrapped Krown Wrapped Krown +20.00%
#8 eCash eCash +19.86%
#9 DODO DODO +15.45%
#10 Black Phoenix Black Phoenix +15.04%
Coin of the day
DeFiChain DeFiChain
設定
言語
日本
通貨
USD
テーマ
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
株式のランク #16315
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
株価
$0.94180721
時価総額
$22.26M
変化（1日）
0.38%
変化（1年）
-14.35%
国
FR
取引 Valbiotis SA (ALVAL)

カテゴリー

Healthcare
Valbiotis SA（ALVAL）の株価履歴
終値の最高値: $0.95 （2026-07-01）

終値の最安値: $11.52 （2017-06-01）
Valbiotis SA の株価履歴（2017 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) -15.31%
2025 -7.34%
2024 -73.56%
2023 44.27%
2022 -51.96%
2021 6.16%
2020 207.03%
2019 -38.49%
2018 -47.84%
2017 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $49.07 -27.00%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $476.31 2.61%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $656.12 19.74%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $277.09 39.62%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $859.43 54.58%
NL